SCHEMBL31411299

SCHEMBL31411299

CCN(C)CCc1n[nH]c2ccc(OC)c(F)c12

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 4/20 0.46
▸ HTR7 P34969 2/20 0.38
▸ HTR6 P50406 2/20 0.38
▸ HTR2A P28223 5/20 0.36
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ BLM P54132 1/20 0.34
▸ PMP22 Q01453 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ DRD2 P14416 2/20 0.32
▸ HTR2C P28335 2/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ MAPK8 P45983 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31411452 0.88 HTR1A (0.59) HTR1AHTR7HTR6HTR2ACYP1A2
SCHEMBL31411322 0.84 HTR2A (0.39) HTR7HTR6HTR2ADRD2HTR2C
SCHEMBL31411312 0.84 HTR1A (0.45) HTR1AHTR7HTR6HTR2AMAPK8
SCHEMBL31411359 0.82 HTR2A (0.36) HTR1AHTR2ADRD2HTR2C
SCHEMBL31411272 0.80 HTR2A (0.36) HTR1AHTR2ACYP1A2CYP3A4CYP2D6
SCHEMBL31411332 0.80 ALDH1A1 (0.36) HTR1AHTR2ACYP1A2CYP3A4CYP2D6
SCHEMBL25748550 0.76 HTR1A (0.79) HTR1AHTR7HTR6HTR2ACYP1A2
Fumaric Acid SCHEMBL31411314 0.75 HTR2A (0.33) HTR1AHTR7HTR6HTR2APMP22
SCHEMBL31411383 0.75 HTR1A (0.46) HTR1AHTR2ACYP1A2CYP3A4CYP2D6
SCHEMBL31411368 0.72 HTR2A (0.40) HTR1AHTR2ADRD2HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4735425-A1 COMPOUNDS Psylo Pty Ltd (AU) 2026-05-06 — — EP disclosed
US-20250353818-A1 Compounds Psylo Pty Ltd (AU) 2025-11-20 — — US disclosed
US-12428380-B2 Compounds Psylo Pty Ltd (AU) 2025-09-30 — — US disclosed
US-20250214943-A1 Compounds Psylo Pty Ltd (AU) 2025-07-03 — — US disclosed
WO-2025000053-A1 COMPOUNDS Psylo Pty Ltd (AU) 2025-01-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250214943-A1 Compounds NLN, SLC18A2, PYGB HTR1A 185/4885HTR7 192/4885HTR6 54/4885
US-12428380-B2 Compounds NLN, SLC18A2, PYGB HTR1A 185/4885HTR7 192/4885HTR6 54/4885
US-20250353818-A1 Compounds NLN, SLC18A2, PYGB HTR1A 185/4885HTR7 192/4885HTR6 54/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback